Abbott said it will use the study results to secure FDA approval for the TactiFlex Duo catheter that offers both PFA and RF energy for tailoring treatment of atrial fibrillation.
Abbott ablation device effective at 1 year in complex cases
Abbott said it will use the study results to secure FDA approval for the TactiFlex Duo catheter that offers both PFA and RF energy for tailoring treatment of atrial fibrillation.